中科信息(300678.SZ):在智能製造領域的菸草物理檢測產品已暢銷海外
格隆匯4月16日丨中科信息(300678.SZ)於近期投資者關係活動表示,公司在智能製造領域的菸草物理檢測產品已暢銷海外。全資子公司瑞拓科技是從事菸草物理檢測設備研發、生產和銷售的專精特新企業,相關產品出口到韓國、阿聯酋、迪拜等國家。在鈔票印製檢測領域,公司參股公司中鈔科信已經佔領國內80%的份額,產品不僅打破了國外壟斷,還出口到匈牙利、哥倫比亞、印度、泰國等海外市場,深受用戶好評。此外,公司也在積極研討數字會議產品、智能裝載機器人、工業視覺檢測軟件等向海外市場的推廣應用,以進一步拓展海外業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.